{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T06:03:01Z","timestamp":1784872981822,"version":"3.55.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Thyroid Eye Disease (TED) may occur in patients with Graves\u2019 disease (GD) either as an isolated condition (iGD) or in the context of autoimmune polyglandular syndromes (aGD). Whether the presence of associated autoimmune diseases influences the severity of TED remains controversial. This study aimed to evaluate the prevalence of autoimmune-associated Graves\u2019 disease (aGD) among patients with moderate-to-severe, active TED requiring high-dose intravenous steroid therapy (IVS), and to characterize the associated autoimmune conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective multicenter study including GD patients treated with IVS for moderate-to-severe, active TED at two Italian tertiary referral centers. Patients were classified as having iGD or aGD based on the presence of concomitant autoimmune diseases. Demographic data, smoking status, thyroid parameters, steroid dose, and response to therapy were collected.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 159 patients were included (mean age 51.7 \u00b1 13.6 years; 27% males). Twelve patients (7.5%) had aGD, while 147 (92.5%) had iGD. Type 1 diabetes mellitus and rheumatoid arthritis were the most frequent associated autoimmune conditions. All aGD patients were female. No significant differences were observed between aGD and iGD patients in age, smoking status, cumulative steroid dose, or response to intravenous glucocorticoid therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Associated autoimmune diseases are uncommon among GD patients with moderate-to-severe TED requiring intravenous glucocorticoids. The possible role of poly-autoimmunity in the pathogenesis and progression of severe TED warrants confirmation in larger prospective studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1824627","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T05:32:44Z","timestamp":1784871164000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Thyroid eye disease in the context of autoimmune polyglandular syndromes: comparative clinical insights from a retrospective study"],"prefix":"10.3389","volume":"17","author":[{"given":"Laura","family":"Croce","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and Therapeutics, University of Pavia","place":["Pavia, Italy"]},{"name":"Unit of Endocrinology and Metabolism, Laboratory for Endocrine Disruptors, Istituti Clinici Scientifici Maugeri Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)","place":["Pavia, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Gatta","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Sciences, Struttura Semplice Dipartimentale (SSD) Endocrinologia, University of Brescia, Azienda Socio Sanitaria Territoriale (ASST) Spedali Civili","place":["Brescia, Italy"]},{"name":"Centro per la Diagnosi e Cura delle Neoplasie Endocrine e delle Malattie della Tiroide, University of Brescia","place":["Brescia, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Gallo","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Therapeutics, University of Pavia","place":["Pavia, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilenia","family":"Pirola","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Sciences, Struttura Semplice Dipartimentale (SSD) Endocrinologia, University of Brescia, Azienda Socio Sanitaria Territoriale (ASST) Spedali Civili","place":["Brescia, Italy"]},{"name":"Centro per la Diagnosi e Cura delle Neoplasie Endocrine e delle Malattie della Tiroide, University of Brescia","place":["Brescia, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marsida","family":"Teliti","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Therapeutics, University of Pavia","place":["Pavia, Italy"]},{"name":"Unit of Endocrinology and Metabolism, Laboratory for Endocrine Disruptors, Istituti Clinici Scientifici Maugeri Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)","place":["Pavia, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Coperchini","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Therapeutics, University of Pavia","place":["Pavia, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Magri","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Therapeutics, University of Pavia","place":["Pavia, Italy"]},{"name":"Unit of Endocrinology and Metabolism, Laboratory for Endocrine Disruptors, Istituti Clinici Scientifici Maugeri Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)","place":["Pavia, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Cappelli","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Sciences, Struttura Semplice Dipartimentale (SSD) Endocrinologia, University of Brescia, Azienda Socio Sanitaria Territoriale (ASST) Spedali Civili","place":["Brescia, Italy"]},{"name":"Centro per la Diagnosi e Cura delle Neoplasie Endocrine e delle Malattie della Tiroide, University of Brescia","place":["Brescia, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Rotondi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Therapeutics, University of Pavia","place":["Pavia, Italy"]},{"name":"Unit of Endocrinology and Metabolism, Laboratory for Endocrine Disruptors, Istituti Clinici Scientifici Maugeri Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)","place":["Pavia, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2022.29143.wie","article-title":"Worldwide consensus on thyroid eye disease? What is in a name","volume":"32","author":"Wiersinga","year":"2022","journal-title":"Thyroid"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1083886","article-title":"Thyroid eye disease or Graves' orbitopathy: What name to use, and why it matters","volume":"13","author":"Wagner","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14296","article-title":"Prevalence of thyroid eye disease in Graves' disease: A meta-analysis and systematic review","volume":"93","author":"Chin","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01479-z","article-title":"Change in newly diagnosed Graves' disease phenotype between the twentieth and the twenty-first centuries: meta-analysis and meta-regression","volume":"44","author":"Ippolito","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-3873","article-title":"Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed graves' hyperthyroidism seen at a single center","volume":"98","author":"Tanda","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-016-0516-7","article-title":"The phenotype of newly diagnosed Graves' disease in Italy in recent years is milder than in the past: results of a large observational longitudinal study","volume":"39","author":"Bartalena","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1160172","article-title":"Influence of biological sex, age and smoking on Graves' orbitopathy - a ten-year tertiary referral center analysis","volume":"14","author":"Oeverhaus","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12222","article-title":"Smoking and thyroid","volume":"79","author":"Wiersinga","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2021.11.080","article-title":"Characteristics of diabetic and nondiabetic patients with thyroid eye disease in the United States: A claims-based analysis","volume":"28","author":"Patel","year":"2022","journal-title":"Endocr Pract"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1251209","article-title":"HbA1c: an independent risk factor for dysthyroid optic neuropathy","volume":"14","author":"Wang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-018-0915-z","article-title":"Relationship between serum cholesterol and Graves' orbitopathy (GO): a confirmatory study","volume":"41","author":"Lanzolla","year":"2018","journal-title":"J Endocrinol Invest"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-18-0039","article-title":"Predictive score for the development or progression of Graves' orbitopathy in patients with newly diagnosed Graves' hyperthyroidism","volume":"178","author":"Wiersinga","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01353-y","article-title":"Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves' orbitopathy","volume":"44","author":"Nicol\u00ec","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-025-02653-x","article-title":"Process to radioactive iodine treatment for Graves' hyperthyroidism: condemned or absolved","volume":"48","author":"Bartalena","year":"2025","journal-title":"J Endocrinol Invest"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-0479","article-title":"The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy","volume":"185","author":"Bartalena","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2022.0251","article-title":"Management of thyroid eye disease: A consensus statement by the American Thyroid Association and the European Thyroid Association","volume":"32","author":"Burch","year":"2022","journal-title":"Thyroid"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-0148","article-title":"Randomized, single blind trial of intravenous versus oral steroid monotherapy in Graves' orbitopathy","volume":"90","author":"Kahaly","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.13608","article-title":"Comparison of efficacy and safety of parenteral versus parenteral and oral glucocorticoid therapy in Graves' orbitopathy","volume":"74","author":"Nedeljkovic Beleslin","year":"2020","journal-title":"Int J Clin Pract"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910434","article-title":"Teprotumumab for the treatment of active thyroid eye disease","volume":"382","author":"Douglas","year":"2020","journal-title":"N Engl J Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1210\/clinem\/dgae526","article-title":"Effectiveness of different treatment modalities in initial and chronic phases of thyroid eye disease: A systematic review with meta-analysis","volume":"109","author":"Alves Junior","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2025.3974","article-title":"Tofacitinib for refractory thyroid eye disease","volume":"143","author":"Ghahvehchian","year":"2025","journal-title":"JAMA Ophthalmol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(21)00238-2","article-title":"Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial","volume":"9","author":"Lanzolla","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-021-07003-0","article-title":"Proposing a surgical algorithm for graduated orbital decompression in patients with Graves' orbitopathy","volume":"279","author":"St\u00e4hr","year":"2022","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.12688\/f1000research.11535.1","article-title":"Recent advances in understanding autoimmune thyroid disease: the tallest tree in the forest of polyautoimmunity","volume":"6","author":"Bliddal","year":"2017","journal-title":"F1000Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1713301","article-title":"Autoimmune polyendocrine syndromes","volume":"378","author":"Husebye","year":"2018","journal-title":"N Engl J Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2018.10.001","article-title":"The association of other autoimmune diseases in patients with Graves' disease (with or without ophthalmopathy): Review of the literature and report of a large series","volume":"18","author":"Ferrari","year":"2019","journal-title":"Autoimmun Rev"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaf144","article-title":"Clinical phenotype of Graves disease in autoimmune polyglandular syndrome or as isolated disease: The GRAPHE study","volume":"110","author":"Gatta","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14304","article-title":"Prevalence of latent and overt polyautoimmunity in autoimmune thyroid disease: A systematic review and meta-analysis","volume":"93","author":"Botello","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-019-01094-7","article-title":"The clinical phenotype of Graves' disease occurring as an isolated condition or in association with other autoimmune diseases","volume":"43","author":"Rotondi","year":"2020","journal-title":"J Endocrinol Invest"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.644200","article-title":"Association of other autoimmune diseases with thyroid eye disease","volume":"12","author":"Kelada","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-022-01906-3","article-title":"Anti-nuclear autoantibodies in Graves' disease and Graves' orbitopathy","volume":"46","author":"Lanzolla","year":"2023","journal-title":"J Endocrinol Invest"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1434155","article-title":"Age and gender influence on clinical manifestations of thyroid-associated ophthalmopathy: a case series of 2479 Chinese patients","volume":"15","author":"Yang","year":"2024","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1824627\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T05:32:44Z","timestamp":1784871164000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1824627\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":32,"alternative-id":["10.3389\/fendo.2026.1824627"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1824627","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"article-number":"1824627"}}